Monkey IgG gamma Antibody Peroxidase Conjugated
Goat Polyclonal
16 References
617-103-012
1 mg
Lyophilized
WB, ELISA, Biochemical Assay, Functional Assay
Monkey
Goat
Shipping info:
$50.00 to US & $70.00 to Canada for most products. Final costs are calculated at checkout.
Product Details
Goat Anti-Monkey IgG (gamma chain) Antibody Peroxidase Conjugated - 617-103-012
goat anti-Monkey IgG (gamma chain) peroxidase conjugated antibody, goat anti-Monkey IgG gamma antibody HRP conjugation
Goat
IgG (gamma chain)
Peroxidase (HRP)
Polyclonal
IgG
Target Details
Monkey
Native Protein
Anti-Monkey IgG (gamma chain) was produced by repeated immunization with monkey IgG gamma heavy chain in goat.
MONKEY IgG gamma Antibody Peroxidase Conjugated was prepared from monospecific antiserum by immunoaffinity chromatography using Monkey IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities. Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-Peroxidase, anti-Goat Serum, Monkey IgG and Monkey Serum.
Application Details
ELISA, WB
Biochemical Assay, Functional Assay
- View References
Anti-Monkey IgG (gamma chain) peroxidase conjugated antibody has been tested by ELISA and western blot and is suitable for immunoblotting (western or dot blot), ELISA, immunoperoxidase electron microscopy and immunohistochemistry as well as other peroxidase-antibody based enzymatic assays requiring lot-to-lot consistency.
Formulation
1.0 mg/mL by UV absorbance at 280 nm
0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
0.01% (w/v) Gentamicin Sulfate. Do NOT add Sodium Azide!
10 mg/mL Bovine Serum Albumin (BSA) - Immunoglobulin and Protease free
1.0 mL
Restore with deionized water (or equivalent)
Shipping & Handling
Ambient
Store vial at 4° C prior to restoration. For extended storage aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
Expiration date is one (1) year from date of receipt.
Anti-Monkey IgG (gamma chain) peroxidase conjugated antibody generated in goat detects specifically Monkey IgG (gamma chain). This secondary peroxidase conjugated antibody anti-Monkey is ideal for investigators who routinely perform titration assays, western-blot, immunoprecipitation and more generally immunoassays.
Smith TJ. et al. (2024). Engineered IgM and IgG cleaving enzymes for mitigating antibody neutralization and complement activation in AAV gene transfer. Mol Ther.
Applications
EIA, ELISA
Kim JY et al. (2023). Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV. Sci Rep.
Applications
EIA, ELISA
Dijkman K et al. (2021). Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection. Cell Rep Med.
Applications
E, EIA
Saunders KO et al. (2020). Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates. Nature.
Applications
E, EIA
Blasi M et al. (2020). Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques. NPJ Vaccines.
Applications
E, EIA
Blasi M et al. (2020). Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs. NPJ Vaccines.
Applications
E, EIA
Felber BK. et al. (2020). Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge. Cell Rep.
Applications
E, EIA; In Vitro Binding Assay
Blasi, M et al. (2020). Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques. Npj Vaccines
Applications
EIA, ELISA
Asbach B et al. (2019). Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost. J Virol.
Applications
E, EIA
Kibler KV et al. (2019). Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques compared to nonreplicating NYVAC. J Virol.
Applications
E, EIA
Bissel SJ et al. (2018). Aged Chinese-origin rhesus macaques infected with SIV develop marked viremia in absence of clinical disease, inflammation or cognitive impairment. Retrovirology
Applications
E, EIA
Furuyama W et al. (2017). Quantification of Filovirus glycoprotein-specific antibodies. Methods Cell Biol.
Applications
E, EIA
Luo et al. (2016). Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques. JCI Insight
Applications
E, EIA
Friedrich BM et al. (2016). ELISA and Neutralization Methods to Measure Anti-West Nile Virus Antibody Responses. Methods Mol Biol.
Applications
E, EIA
Caro-Aguilar I et al. (2013). Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197. Hum Vaccin Immunother.
Applications
E, EIA
Fouda GGA et al. (2013). Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk. J Viral.
Applications
E, EIA
This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.
